Replies to post #773357 on NorthWest Biotherapeutics Inc (NWBO)

[GoodGuyBill]

My statement:

2. Evolving regulatory framework has effectively shifted toward the very trial design pioneered by NWBO in its DCVax-L Phase III study.

Go ahead and focus on that minute bullshit, "pioneered" when you know the gist of the point here is that the MHRA has shifted to the designed "used" by NWBO's dcvax-l trial! But go ahead and keep majoring in the minors and making a distinction without a difference. BUT YOU KNOW MY POINT IS ACCURATE!!!

Now continue with your bs... you're a hoot and very entertaining... it will be over soon, lol!